Experienced in Chronic Lymphocytic Leukemia (CLL)

Dr. Aaron Provenzano

Hematology Oncology | Oncology
Oncology Hematology Association Inc
470 Johnson Rd, Suite 10, 
Washington, PA 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Chronic Lymphocytic Leukemia (CLL)
Oncology Hematology Association Inc
470 Johnson Rd, Suite 10, 
Washington, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Aaron Provenzano is a Hematologist Oncology specialist and an Oncologist in Washington, Pennsylvania. Dr. Provenzano is rated as an Experienced provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Hemophilia B.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Oncology
Licenses
Internal Medicine in OH
Hospital Affiliations
Wheeling Hospital, Inc
Trinity Medical Ctr East &Trinity Medical Ctr West
Weirton Medical Center, Inc
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

ONCOLOGY HEMATOLOGY ASSOCIATION INC
470 Johnson Rd, Suite 10, Washington, PA 15301
Call: 724-223-3816
Other Locations
ONCOLOGY HEMATOLOGY ASSOCIATION INC
3204 Johnson Rd, Steubenville, OH 43952
Call: 740-266-3900

Additional Areas of Focus

Dr. Provenzano has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Enrollment Status: Recruiting
Publish Date: January 12, 2026
Intervention Type: Drug
Study Drugs: Vismodegib, GSK2256098, Capivasertib, Abemaciclib
Study Phase: Phase 2
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2026
Intervention Type: Drug, Radiation
Study Drugs: Concomitant Temozolomide (TMZ), Procarbazine, Adjuvant Temozolomide (TMZ), CCNU, Vincristine
Study Phase: Phase 3
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: November 28, 2025
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
Use of Response-Adapted Hypofractionated Radiation Therapy to Potentiate the Systemic Immune Response to Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Use of Response-Adapted Hypofractionated Radiation Therapy to Potentiate the Systemic Immune Response to Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: April 01, 2025
Intervention Type: Radiation, Drug
Study Phase: Not Applicable
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
Methionine-Restricted Diet to Potentiate The Effects of Radiation Therapy
Methionine-Restricted Diet to Potentiate The Effects of Radiation Therapy
Enrollment Status: Terminated
Publish Date: April 25, 2023
Intervention Type: Dietary supplement
Study Phase: Not Applicable
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug, Other
Study Phase: Phase 2
View 6 Less Clinical Trials

1 Total Publications

Overcoming endocrine resistance in breast cancer: role of the PI3K and the mTOR pathways.
Overcoming endocrine resistance in breast cancer: role of the PI3K and the mTOR pathways.
Journal: Expert review of anticancer therapy
Published: February 15, 2013
Similar Doctors
Distinguished in Chronic Lymphocytic Leukemia (CLL)
Dr. Salman S. Osman
Hematology Oncology | Hematology | Oncology
Distinguished in Chronic Lymphocytic Leukemia (CLL)
Dr. Salman S. Osman
Hematology Oncology | Hematology | Oncology

United Hospital Center Inc

327 Medical Park Dr, 
Bridgeport, WV 
 (61.7 miles away)
681-342-3153
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Salman Osman is a Hematologist Oncology specialist and a Hematologist in Bridgeport, West Virginia. Dr. Osman is rated as a Distinguished provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Ampullary Cancer, Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Bone Marrow Aspiration. Dr. Osman is currently accepting new patients.

Distinguished in Chronic Lymphocytic Leukemia (CLL)
Dr. Kevin J. Shannon
Hematology Oncology | Hematology | Oncology
Distinguished in Chronic Lymphocytic Leukemia (CLL)
Dr. Kevin J. Shannon
Hematology Oncology | Hematology | Oncology

West Virginia University Medical Corporation

1 Medical Ctr Dr, 
Morgantown, WV 
 (41.3 miles away)
304-293-4500
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kevin Shannon is a Hematologist Oncology specialist and a Hematologist in Morgantown, West Virginia. Dr. Shannon is rated as a Distinguished provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Chronic Lymphocytic Leukemia (CLL), and Small Cell Lung Cancer (SCLC). Dr. Shannon is currently accepting new patients.

Distinguished in Chronic Lymphocytic Leukemia (CLL)
Dr. Abdalla M. Sholi
Hematology Oncology | Hematology | Oncology
Distinguished in Chronic Lymphocytic Leukemia (CLL)
Dr. Abdalla M. Sholi
Hematology Oncology | Hematology | Oncology

Phoenix Rehabilitation And Health Services Inc

2000 Westinghouse Dr, Suite 200, 
Cranberry Township, PA 
 (32.4 miles away)
Languages Spoken:
English
See accepted insurances

Abdalla Sholi is a Hematologist Oncology specialist and a Hematologist in Cranberry Township, Pennsylvania. Dr. Sholi is rated as a Distinguished provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Inflammatory Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC).

VIEW MORE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Provenzano's expertise for a condition
ConditionClose
    • Distinguished
    • Astrocytoma
      Dr. Provenzano is
      Distinguished
      . Learn about Astrocytoma.
      See more Astrocytoma experts
    • Atypical Teratoid Rhabdoid Tumor (ATRT)
      Dr. Provenzano is
      Distinguished
      . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
      See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
    • Embryonal Tumor with Multilayered Rosettes
      Dr. Provenzano is
      Distinguished
      . Learn about Embryonal Tumor with Multilayered Rosettes.
      See more Embryonal Tumor with Multilayered Rosettes experts
    • Gliosarcoma
      Dr. Provenzano is
      Distinguished
      . Learn about Gliosarcoma.
      See more Gliosarcoma experts
    • Hemophilia B
      Dr. Provenzano is
      Distinguished
      . Learn about Hemophilia B.
      See more Hemophilia B experts
    • Lung Cancer
      Dr. Provenzano is
      Distinguished
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    View All 10 Distinguished Conditions
    • Advanced
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Provenzano is
      Advanced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Brain Tumor
      Dr. Provenzano is
      Advanced
      . Learn about Brain Tumor.
      See more Brain Tumor experts
    • Breast Cancer
      Dr. Provenzano is
      Advanced
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Childhood Iron Deficiency Anemia
      Dr. Provenzano is
      Advanced
      . Learn about Childhood Iron Deficiency Anemia.
      See more Childhood Iron Deficiency Anemia experts
    • Colorectal Cancer
      Dr. Provenzano is
      Advanced
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • EGFR Positive Lung Cancer
      Dr. Provenzano is
      Advanced
      . Learn about EGFR Positive Lung Cancer.
      See more EGFR Positive Lung Cancer experts
    View All 27 Advanced Conditions
    • Experienced
    • Acinic Cell Carcinoma of Salivary Glands
      Dr. Provenzano is
      Experienced
      . Learn about Acinic Cell Carcinoma of Salivary Glands.
      See more Acinic Cell Carcinoma of Salivary Glands experts
    • Acute Eosinophilic Pneumonia
      Dr. Provenzano is
      Experienced
      . Learn about Acute Eosinophilic Pneumonia.
      See more Acute Eosinophilic Pneumonia experts
    • Acute Mountain Sickness
      Dr. Provenzano is
      Experienced
      . Learn about Acute Mountain Sickness.
      See more Acute Mountain Sickness experts
    • Acute Promyelocytic Leukemia
      Dr. Provenzano is
      Experienced
      . Learn about Acute Promyelocytic Leukemia.
      See more Acute Promyelocytic Leukemia experts
    • Adenoid Cystic Carcinoma
      Dr. Provenzano is
      Experienced
      . Learn about Adenoid Cystic Carcinoma.
      See more Adenoid Cystic Carcinoma experts
    • Adult Soft Tissue Sarcoma
      Dr. Provenzano is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    View All 110 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.